Want to see FR:ALTME full AI Analyst Report?
TME Pharma N.V. (ALTME) Financial Statements
TME Pharma N.V. Financial Overview
TME Pharma N.V.'s market cap is currently $11.77M. The company's EPS TTM is $-0.03; its P/E ratio is -3.55; TME Pharma N.V. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 19.00K | $ 17.00K | $ 0.00 | $ 33.00K |
| Gross Profit | $ -8.00K | $ -78.00K | $ -127.00K | $ -92.00K | $ -65.97K |
| Operating Income | $ -2.91M | $ -5.28M | $ -5.62M | $ -12.03M | $ -13.27M |
| EBITDA | $ -2.90M | $ -5.17M | $ -5.07M | $ -11.63M | $ -12.88M |
| Net Income | $ -3.29M | $ -5.72M | $ -6.74M | $ -15.13M | $ -14.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.02M | $ 3.25M | $ 2.25M | $ 4.63M | $ 9.48M |
| Total Assets | $ 2.14M | $ 3.41M | $ 2.49M | $ 5.24M | $ 9.77M |
| Total Debt | $ 2.39M | $ 56.00K | $ 1.17M | $ 4.09M | $ 2.44M |
| Net Debt | $ 376.00K | $ -3.24M | $ -1.08M | $ -548.00K | $ -7.02M |
| Total Liabilities | $ 3.72M | $ 1.79M | $ 2.79M | $ 6.51M | $ 5.27M |
| Stockholders' Equity | $ -1.58M | $ 1.61M | $ -294.00K | $ -1.27M | $ 4.51M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.42M | $ -4.65M | $ -5.65M | $ -12.16M | $ -12.39M |
| Operating Cash Flow | $ -3.42M | $ -4.63M | $ -5.63M | $ -12.14M | $ -12.38M |
| Investing Cash Flow | $ 8.00K | $ -21.00K | $ -19.00K | $ -21.00K | $ -14.00K |
| Financing Cash Flow | $ 2.18M | $ 5.66M | $ 3.27M | $ 7.29M | $ 11.50M |
Currency in EUR